MannKind Corporation
MNKDBiotechnology
$3.50+2.04%As of Oct 29vs prior close
- Market cap
- $1.1B
- P/E (TTM)
- –
- P/E (FY1)
- 140.0×
- From 52W high
- −43.64%
- EPS (LTM)
- -$0.13
- Revenue (LTM)
- $393.6M
- Net margin
- -11.08%
- Dividend yield
- 0.00%
Nomior Score
44
Anchored CompounderBottom 37% of the scored universe
Growth53
Quality72
Value50
Momentum25
Resilience36
Growth
+7.99%revenue a year over 9 fiscal years
YE16 $174.8MLTM $393.6M
Connections
Revenue to profitQ2 YE26
The operating loss was 0% of revenue, wider by 7 pts on a year.
Who owns it
2funds